Malpani Ventures

Malpani Ventures

Malpani Ventures operates as the family investment office of Dr. Aniruddha Malpani, whose primary wealth originates from his long-running Malpani Infertility Clinic in Mumbai. The firm started deploying personal capital into early-stage technology companies around 2012, building a concentrated portfolio that spans health-tech, enterprise SaaS, fintech, and consumer internet. Its mandate is capital from a single family balance sheet, which eliminates external LP-pressure on exit timelines or fund cycles. The firm's deployment centers on pre-seed and seed rounds, with standard checks ranging from $100,000 to $500,000. It occasionally participates in follow-on rounds for portfolio companies that show strong unit economics. Known positions include health-insurance platform Plum, fintech infrastructure provider Decentro, and digital health startup BeatO. Malpani Ventures often co-invests alongside other prominent Indian angel networks and micro-VCs such as Indian Angel Network and First Cheque. The geographical focus remains squarely on India, though the firm has shown interest in Indian founders building globally. The portfolio has grown to over 60 active companies, making it one of the more active single-family offices in India's early-stage ecosystem. Dr. Malpani is also a limited partner in several venture funds, including India Quotient and First Cheque, which creates a sourcing flywheel — the fund relationships generate deal flow, while the direct investment vehicle allows for concentrated bets. In 2022, Malpani publicly committed to increasing his allocation to direct startup investments, signaling a long-term shift away from public market assets (per the firm's official communications, 2022). The office's structural differentiator lies in its operator-LP hybrid model. Most Indian family offices operate as passive allocators; Malpani Ventures functions like an angel syndicate with permanent capital. The principal makes investment decisions personally, often writing checks within a week of a first meeting. The absence of an institutional investment committee permits rapid execution, while the medical-practice origin provides a genuine operator's lens on health-tech and consumer-facing businesses — a sharp contrast to family offices rooted in real estate or manufacturing.